# EDGAR Filing Document

**Accession Number:** 0001347242
**File Stem:** 0001753926-23-000113
**Filing Date:** 2023-2
**Character Count:** 6862
**Document Hash:** 3465aa3173adfc3820884182731296d1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-23-000113.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001753926-23-000113

**CONFORMED SUBMISSION TYPE**: SC 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LIPELLA PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0001347242
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93847
- **FILM NUMBER:** 23605864

**BUSINESS ADDRESS:**
- **STREET 1:** 400 N LEXINGTON ST
- **STREET 2:** STE LL103
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15208
- **BUSINESS PHONE:** 412-901-0315

**MAIL ADDRESS:**
- **STREET 1:** 400 N LEXINGTON ST
- **STREET 2:** STE LL103
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15208
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Huang Leaf
- **CENTRAL INDEX KEY:** 0001959358

**FILING VALUES:**
- **FORM TYPE:** SC 13G

**MAIL ADDRESS:**
- **STREET 1:** C/O LIPELLA PHARMACEUTICALS INC.
- **STREET 2:** 7800 SUSQUEHANNA ST., SUITE 505
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15208

**SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934<br> (Amendment No.)\***

Lipella Pharmaceuticals Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

53630L100

(CUSIP Number)

December 31, 2022

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)<br> ☐ Rule 13d-1(c)<br> ☒ Rule 13d-1(d)

<sup>\*</sup> The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 53630L100 13G Page 2 of 6 Pages

1. NAMES OF REPORTING PERSONS <br> I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) <br>
<br> Leaf Huang

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP <br> (see instructions) <br> (a) ☐ <br> (b) ☐

3. SEC USE ONLY <br>

4. CITIZENSHIP OR PLACE OF ORGANIZATION <br>United States

---

| | | |
|:---|:---|:---|
| NUMBER OF <br> SHARES <br> BENEFICIALLY <br> OWNED BY <br> EACH <br> REPORTING <br> PERSON WITH | 5. | SOLE VOTING POWER<br>555,556 |
| NUMBER OF <br> SHARES <br> BENEFICIALLY <br> OWNED BY <br> EACH <br> REPORTING <br> PERSON WITH | 6. | SHARED VOTING POWER<br>0<br>|
| NUMBER OF <br> SHARES <br> BENEFICIALLY <br> OWNED BY <br> EACH <br> REPORTING <br> PERSON WITH | 7. | SOLE DISPOSITIVE POWER<br>555,556 |
| NUMBER OF <br> SHARES <br> BENEFICIALLY <br> OWNED BY <br> EACH <br> REPORTING <br> PERSON WITH | 8. | SHARED DISPOSITIVE POWER<br>0 |

---

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>
<br> 555,556

10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES <br> (see instructions) ☐

11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>
<br> 9.7% (1)

12. TYPE OF REPORTING PERSON (see instructions) <br>
<br> IN

(1) The percentage set forth in row (11) is based on 5,743,945 shares of issuer's common stock, par value $0.0001 per share ("Common Stock"), outstanding as of December 22, 2022 following the issuer's initial public offering of Common Stock, as disclosed in the prospectus, dated December 19, 2022, filed by the issuer pursuant to Rule 424 of the Securities Act of 1933, as amended, with the U.S. Securities and Exchange Commission on December 21, 2022.

CUSIP No. 53630L100 13G Page 3 of 6 Pages

**Item 1**

(a) Name of Issuer:

Lipella Pharmaceuticals Inc. (the "Issuer")

(b) Address of Issuer's Principal Executive Offices:

7800 Susquehanna Street, Suite 505

Pittsburgh, Pennsylvania 15208

**Item 2. Names of Persons Filing:**

(a) Name of Person Filing:

Leaf Huang (the "Reporting Person")

(b) Address of Principal Business Office or, if none, Residence:

Eshelman School of Pharmacy

University of North Carolina at Chapel Hill

301 Pharmacy Lane

Chapel Hill, North Carolina 27599

(c) Citizenship:

United States of America

(d) Title of Class of Securities:

common stock, par value $0.0001 per share, of the Issuer

(e) CUSIP Number:

53630L100

CUSIP No. 53630L100 13G Page 4 of 6 Pages

**Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:**

Not applicable.

**Item 4. Ownership.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Amount beneficially owned: 555,556

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Percent of class: 9.7%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Number of shares as to which the Reporting Person has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Sole power to vote or to direct the vote: 555,556

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Shared power to vote or to direct the vote : 0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Sole power to dispose or direct the disposition of: 555,556

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Shared power to dispose or direct the disposition: 0

**Item 5. Ownership of Five Percent or Less of a Class.**

Not applicable.

**Item 6. Ownership of More than Five Percent on Behalf of Another Person.**

Not applicable.

CUSIP No. 53630L100 13G Page 5 of 6 Pages

**Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.**

Not applicable.

**Item 8. Identification and Classification of Members of the Group.**

Not applicable.

**Item 9. Notice of Dissolution of Group.**

Not applicable.

**Item 10. Certification.**

Not applicable.

CUSIP No. 53630L100 13G Page 6 of 6 Pages

**SIGNATURE**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | |
|:---|:---|
| Date: February 9, 2023 |  |
|  | /s/ Leaf Huang |
|  | Name: Leaf Huang |

---